81 related articles for article (PubMed ID: 18497075)
1. Expression analysis of human endometrial adenocarcinoma in an inbred rat model.
Karlsson S; Klinga-Levan K
Adv Exp Med Biol; 2008; 617():503-9. PubMed ID: 18497075
[TBL] [Abstract][Full Text] [Related]
2. Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer.
Karlsson S; Holmberg E; Askerlund A; Levan KK
Cancer Genet Cytogenet; 2007 Aug; 177(1):43-50. PubMed ID: 17693190
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model.
Roshani L; Mallon P; Sjostrand E; Wedekind D; Szpirer J; Szpirer C; Hedrich HJ; Klinga-Levan K
Cancer Genet Cytogenet; 2005 Apr; 158(2):137-41. PubMed ID: 15796960
[TBL] [Abstract][Full Text] [Related]
4. Amplification studies of MET and Cdk6 in a rat endometrial tumor model and their correlation to human type I endometrial carcinoma tumors.
Samuelson E; Nordlander C; Levan G; Behboudi A
Adv Exp Med Biol; 2008; 617():511-7. PubMed ID: 18497076
[TBL] [Abstract][Full Text] [Related]
5. The impact of the genetic background on the genome make-up of tumor cells.
Falck E; Behboudi A; Klinga-Levan K
Genes Chromosomes Cancer; 2012 May; 51(5):438-46. PubMed ID: 22250046
[TBL] [Abstract][Full Text] [Related]
6. Recurrent chromosome 10 aberrations and Tp53 mutations in rat endometrial adenocarcinomas.
Nordlander C; Samuelson E; Klinga-Levan K; Behboudi A
Adv Exp Med Biol; 2008; 617():519-25. PubMed ID: 18497077
[TBL] [Abstract][Full Text] [Related]
7. Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats.
Samuelson E; Hedberg C; Nilsson S; Behboudi A
Endocr Relat Cancer; 2009 Mar; 16(1):99-111. PubMed ID: 19075038
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization.
Helou K; Walentinsson A; Beckmann B; Johansson A; Hedrich HJ; Szpirer C; Klinga-Levan K; Levan G
Cancer Genet Cytogenet; 2001 Jun; 127(2):118-27. PubMed ID: 11425450
[TBL] [Abstract][Full Text] [Related]
9. [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma].
Jeda A; Witek A; Janikowska G; Cwynar G; Janikowski T; Ciałon M; Orchel J; Mazurek U
Ginekol Pol; 2014 Mar; 85(3):172-9. PubMed ID: 24783427
[TBL] [Abstract][Full Text] [Related]
10. High-density marker loss of heterozygosity analysis of rat chromosome 10 in endometrial adenocarcinoma.
Behboudi A; Levan G; Hedrich HJ; Klinga-Levan K
Genes Chromosomes Cancer; 2001 Dec; 32(4):330-41. PubMed ID: 11746974
[TBL] [Abstract][Full Text] [Related]
11. Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells.
Koistinen H; Seppälä M; Nagy B; Tapper J; Knuutila S; Koistinen R
Am J Obstet Gynecol; 2005 Dec; 193(6):1955-60. PubMed ID: 16325596
[TBL] [Abstract][Full Text] [Related]
12. A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue.
Sugiyama Y; Dan S; Yoshida Y; Akiyama F; Sugiyama K; Hirai Y; Matsuura M; Miyata S; Ushijima M; Hasumi K; Yamori T
Clin Cancer Res; 2003 Nov; 9(15):5589-600. PubMed ID: 14654540
[TBL] [Abstract][Full Text] [Related]
13. Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model.
Roshani L; Wedekind D; Szpirer J; Taib Z; Szpirer C; Beckmann B; Rivière M; Hedrich HJ; Klinga-Levan K
Int J Cancer; 2001 Dec; 94(6):795-9. PubMed ID: 11745480
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization.
Hamta A; Adamovic T; Heloua K; Levan G
Cancer Genet Cytogenet; 2005 Jun; 159(2):123-8. PubMed ID: 15899383
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays.
O'Toole SA; Dunn E; Sheppard BL; Klocker H; Bektic J; Smyth P; Martin C; Sheils O; O'Leary JJ
Int J Gynecol Cancer; 2006; 16(2):834-42. PubMed ID: 16681770
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtypes identified by gene expression profiling in early stage endometrioid endometrial adenocarcinoma.
Gao BR; Chen YH; Yao YY; Li XP; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(19):3680-4. PubMed ID: 24112163
[TBL] [Abstract][Full Text] [Related]
17. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study of gene expression profiling in human type I and II endometrial carcinoma].
Guo SQ; Xing FQ; Pang ZJ; Fang WY; Liu GB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):734-7. PubMed ID: 16793587
[TBL] [Abstract][Full Text] [Related]
19. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
